Brian Culley, Lineage Cell Therapeutics CEO
October 13, 2022 12:37 PM EDTUpdated 05:33 PM
Pharma
Cell/Gene Tx
Manufacturing

Lin­eage Cell Ther­a­peu­tics opens new Cal­i­for­nia R&D fa­cil­i­ty and ex­pands Is­rael man­u­fac­tur­ing site

Tyler Patchen

News Reporter

Last year, Roche and Genen­tech paid $50 mil­lion for li­cens­ing rights to Lin­eage Cell Ther­a­peu­tics’ OpRe­gen pro­gram, a cell ther­a­py that looks to re­gen­er­ate …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times